Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder Clinical research trials and Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder. Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder clinical trial. Human subjects often get the best healthcare possible for their Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.

Home > "E" Clinical Trials Conditions > Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder

Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder



Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder

For Condition: Schizophrenia,Schizoaffective Disorder
Status: Recruiting
Sponsor(s): Janssen Pharmaceutica ,
Synopsis: A study to evaluate the efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Current diagnosis of an acute exacerbation of either schizophrenia or schizoaffective disorder
Total Enrollment: 225

Location and Contact Information:

Institute for Neuropsychiatry *Recruiting*
Lake Charles,  Louisiana,  70601
United States
Recruiting Barbara  Linn 337-494-3266

Neurobehavioral Research, Inc. *Recruiting*
Lawrence,  New York,  11559
United States
Recruiting Barbara  Linn 516-295-7231

Behavioral and Medical Research *Recruiting*
San Diego,  California,  92123
United States
Recruiting Thomas  Rosser 858-571-1188

International Clinical Research Associates, LLCc *Recruiting*
Richmond,  Virginia,  23294
United States
Recruiting Barbara  Linn 804-270-6811

University of MIssissippi Medical Center *Recruiting*
Jackson,  Mississippi,  39216
United States
Recruiting Jennifer  Frantz 601-984-5660

Sharp Mesa Vista Hospital *Recruiting*
San Diego,  California,  92123
United States
Recruiting Thomas  Rosser 858-694-8355

Atlanta Center for Medical Research *Recruiting*
Atlanta,  Georgia,  30308
United States
Recruiting Barbara  Linn 404-881-5800

Clinical Research Inc. *Recruiting*
St. Louis,  Missouri,  63118
United States
Recruiting Barbara  Linn 314-771-6387

Synergy Clinical Research *Recruiting*
Chula Vista,  California,  91910
United States
Recruiting Thomas  Rosser 619-426-7272

University Hills Clinical Research *Recruiting*
Irving,  Texas,  75062
United States
Recruiting Barbara  Linn 972-717-6262

Linden Research Consultants, LLC *Recruiting*
Oklahoma City,  Oklahoma,  73116
United States
Recruiting Barbara  Linn 405-858-7773

Community Clinical Research, Inc *Recruiting*
Austin,  Texas,  78756
United States
Recruiting Barbara  Lynn 512-336-6407

University of California-Irvine *Recruiting*
Orange,  California,  92868
United States
Recruiting Thomas  Rosser 714-456-6315


Additional Information:
Study ID Numbers:
  RIS-SCP-402; 
Study Start Date: June 2003
Record last reviewed: August 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00061802

Other Schizoaffective Disorder Studies:
1. Treatment of Schizophrenia Through Internet-Based Psychoeducation

2. Effects of Modafinil on Brain Function in Patients with Schizophrenia

3. Cognitive - Behavioral Therapy

4. Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder

5. To Determine If Olanzapine Is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia

Related Studies:

Other Schizoaffective Disorder Clinical Trials
Other Louisiana Clinical Trials
Other Lake Charles Clinical Trials

Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder

Modify your Search

  Other Schizoaffective Disorder Clinical Trials
  Other Louisiana Clinical Trials
  Other Lake Charles Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103